Paysign, Inc.
PAYS- Exchange
- Nasdaq
- Industry
- Services-Business Services, NEC
- SEC CIK
- 0001496443
In the last 90 days, Paysign, Inc. insiders filed 0 open-market purchases and 6 sales; 132 institutions reported holding it in 13F filings for Q2 2026, worth $247.8M in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 11, 2026, 1:15 AM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Mar 24, 2026 | Mar 25, 2025 | Mar 26, 2024 | Mar 22, 2023 | Mar 22, 2022 |
| Revenue | $82.0M | $58.4M | $47.3M | $38.0M | $29.5M |
| Cost of revenue | $33.3M | $26.2M | $23.1M | $17.1M | $14.8M |
| Gross profit | $48.7M | $32.2M | $24.1M | $21.0M | $14.7M |
| Operating expenses | $41.4M | $31.2M | $24.3M | $20.6M | $17.5M |
| Selling, general and administrative | $33.0M | $25.2M | $20.3M | $17.7M | $15.0M |
| Operating income | $7.36M | $1.02M | -$167.3K | $344.3K | -$2.74M |
| Income tax | $2.48M | $322.3K | -$4.09M | $107.5K | $10.2K |
| Net income | $7.55M | $3.82M | $6.46M | $1.03M | -$2.72M |
| EPS, basic | $0.14 | $0.07 | $0.12 | $0.02 | $-0.05 |
| EPS, diluted | $0.13 | $0.07 | $0.12 | $0.02 | $-0.05 |
| Weighted shares, basic | 54.4M | 53.2M | 52.5M | 52.0M | 51.0M |
| Weighted shares, diluted | 59.6M | 55.6M | 54.2M | 52.9M | 51.0M |
| Margins and growth | |||||
| Gross margin | 59.4% | 55.1% | 51.1% | 55.1% | 49.9% |
| Operating margin | 9.0% | 1.7% | -0.4% | 0.9% | -9.3% |
| Net margin | 9.2% | 6.5% | 13.7% | 2.7% | -9.2% |
| Revenue growth, year over year | +40.5% | +23.5% | +24.3% | +29.1% | +22.2% |
| Net income growth, year over year | +97.9% | −40.9% | +528.4% | – | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Mar 24, 2026 | Mar 25, 2025 | Mar 26, 2024 | Mar 22, 2023 | Mar 22, 2022 |
| Cash and equivalents | $21.1M | $10.8M | $17.0M | $9.71M | $7.39M |
| Accounts receivable | $72.2M | $32.6M | $16.2M | $4.68M | $3.39M |
| Total current assets | $240.1M | $158.8M | $129.2M | $97.7M | $74.3M |
| Property, plant and equipment | $1.90M | $1.16M | $1.09M | $1.26M | $1.64M |
| Goodwill | $4.49M | – | – | – | – |
| Intangible assets | $22.3M | $12.2M | $8.81M | $5.66M | $4.09M |
| Total assets | $276.3M | $179.0M | $146.6M | $108.2M | $84.1M |
| Short-term debt | $1.86M | – | – | – | – |
| Total current liabilities | $216.3M | $146.1M | $119.2M | $88.6M | $67.4M |
| Long-term debt | $6.14M | – | – | – | – |
| Total liabilities | $227.8M | $148.6M | $122.1M | $92.0M | $71.1M |
| Shareholders' equity | $48.5M | $30.4M | $24.5M | $16.3M | $13.0M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Mar 24, 2026 | Mar 25, 2025 | Mar 26, 2024 | Mar 22, 2023 | Mar 22, 2022 |
| Operating cash flow | $52.5M | $22.9M | $27.6M | $25.3M | $15.2M |
| Capital expenditures | $1.21M | $434.9K | $262.6K | $105.2K | $328.6K |
| Free cash flow | $51.2M | $22.5M | $27.4M | $25.2M | $14.9M |
| Depreciation and amortization | $8.32M | $5.99M | $4.03M | $2.91M | $2.50M |
| Stock-based compensation | $4.26M | $2.60M | $2.85M | $2.28M | $2.28M |
| Share buybacks | $375.8K | $495.0K | $1.13M | – | – |
| Investing cash flow | -$10.1M | -$9.49M | -$7.05M | -$4.09M | -$2.68M |
| Financing cash flow | $284.9K | -$466.2K | -$1.12M | $0 | $192.1K |
| Ratio | |||||
| Stock-based compensation, % of revenue | 5.2% | 4.5% | 6.0% | 6.0% | 7.7% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.